Related references
Note: Only part of the references are listed.Feasibility of Preoperative Chemotherapy with Docetaxel, Cisplatin, and 5-Fluorouracil versus Adriamycin, Cisplatin, and 5-Fluorouracil for Resectable Advanced Esophageal Cancer
Osamu Shiraishi et al.
ONCOLOGY (2017)
Chemoradiotherapy and surgery for T4 esophageal cancer in Japan
Yasunori Akutsu et al.
SURGERY TODAY (2015)
Clinicopathological factors predicting R0 resection and long-term survival after esophagectomy in patients with T4 esophageal cancer undergoing induction chemotherapy or chemoradiotherapy
Hiroyuki Karimata et al.
SURGERY TODAY (2015)
Induction Chemotherapy or Chemoradiotherapy Followed by Radical Esophagectomy for T4 Esophageal Cancer: Results of a Prospective Cohort Study
Hideaki Shimoji et al.
WORLD JOURNAL OF SURGERY (2013)
Clinical relevance of induction triplet chemotherapy for esophageal cancer invading adjacent organs
Hiroshi Miyata et al.
JOURNAL OF SURGICAL ONCOLOGY (2012)
Prognostic Value of Endoscopic Biopsy Findings After Induction Chemoradiotherapy With and Without Surgery for Esophageal Cancer
Hiroshi Miyata et al.
ANNALS OF SURGERY (2011)
Treatment of T4 Esophageal Cancer. Definitive Chemo-Radiotherapy vs Chemo-Radiotherapy Followed by Surgery
Tomoki Makino et al.
ANNALS OF THORACIC AND CARDIOVASCULAR SURGERY (2011)
Multicenter Phase I/II Study of Docetaxel, Cisplatin and Fluorouracil Combination Chemotherapy in Patients with Advanced or Recurrent Squamous Cell Carcinoma of the Esophagus
Makoto Yamasaki et al.
ONCOLOGY (2011)
Histopathologic examination and reporting of esophageal carcinomas following preoperative neoadjuvant therapy
Fuju Chang et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2008)
Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer
Marshall R. Posner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer
Jan B. Vermorken et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Clinical benefit with docetaxel plus fluorouracil and cisplatin compared with cisplatin and fluorouracil in a phase III trial of advanced gastric or gastroesophageal cancer adenocarcinoma: The V-325 study group
Jaffer A. Ajani et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Treatment of thoracic esophageal carcinoma invading adjacent structures
Yasuyuki Seto et al.
CANCER SCIENCE (2007)
Chemoradiotherapy followed by surgery for squamous cell carcinoma of the thoracic esophagus with clinical evidence of adjacent organ invasion
Giovanni De Manzoni et al.
JOURNAL OF SURGICAL ONCOLOGY (2007)
Multimodality treatment of esophageal cancer
Z Gamliel et al.
SURGICAL CLINICS OF NORTH AMERICA (2005)
Esophagectomy: Is it necessary after chemoradiotherapy for a locally advanced T4 esophageal cancer? Prospective nonrandomized trial comparing chemoradiotherapy with surgery versus without surgery
H Fujita et al.
WORLD JOURNAL OF SURGERY (2005)
Resection surgery with neoadjuvant chemoradiotherapy improves outcomes of patients with T4 esophageal carcinoma
T Noguchi et al.
DISEASES OF THE ESOPHAGUS (2003)
Surgical treatment for locally advanced (T4) squamous cell carcinoma of the thoracic esophagus
M Tachibana et al.
DYSPHAGIA (2002)
Prospective trial of concurrent chemoradiotherapy with protracted infusion of 5-fluorouracil and cisplatin for T4 esophageal cancer with or without fistula
Y Nishimura et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2002)
Role of esophagectomy in treatment of esophageal carcinoma with clinical evidence of adjacent organ invasion
T Matsubara et al.
WORLD JOURNAL OF SURGERY (2001)
Chemoradiotherapy followed by surgery for thoracic esophageal cancer potentially or actually involving adjacent organs
K Ikeda et al.
DISEASES OF THE ESOPHAGUS (2001)
Squamous cell carcinoma of the esophagus infiltrating the respiratory tract is less sensitive to preoperative concurrent radiation and chemotherapy
M Yano et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2000)
Share Paper
